Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Scandinavian ChemoTech

3.85 SEK

+1.58 %

Less than 1K followers

CMOTEC B

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Scandinavian ChemoTech

EV/S

Median 2019-2022

P/B

Median 2019-2025

 
2019202020212022202320242025
Share price (SEK)10.0313.0216.374.852.591.795.02
Shares4.56.39.012.518.723.325.5
Market cap44.981.9147.560.748.441.8127.8
Enterprise value47.480.5138.954.8---
EV/S85.2614.32,833.7116.6---
EV/EBITDAneg.neg.neg.neg.---
EV/EBITneg.neg.neg.neg.---
P/Eneg.neg.neg.neg.neg.neg.neg.
P/B4.628.876.174.344.396.9940.11
P/S80.8625.33,009.8129.117.26.410.4
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %
Equity ratio55.6 %57.8 %92.7 %64.5 %74.2 %44.7 %24.1 %
Gearing ratio54.4 %0.6 %0.2 %---206.1 %
Login required

This content is only available for logged in users

Create account
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.